Articles from Antidepressants

FDA approves drug for treating postpartum depression | - KGMI

FDA approves drug for treating postpartum depression |  KGMIBy LINDA A. JOHNSON AP Medical Writer. TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for ...

VA to Offer New Ketamine-Based Nasal Spray for Depression - Military.com

VA to Offer New Ketamine-Based Nasal Spray for Depression  Military.comThe newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will ...

What is esketamine? - Penn: Office of University Communications

What is esketamine?  Penn: Office of University CommunicationsFollowing FDA approval of esketamine as a nasal spray to address otherwise untreatable cases of depression, Michael Thase, a professor of psychiatry at Penn ...

Ketamine for Stress-Related Psychopathology and Suicidality: A Brief Update - Psychiatric Times

Ketamine for Stress-Related Psychopathology and Suicidality: A Brief Update  Psychiatric TimesThis CME provides a comprehensive understanding of psychopharmacologic treatments for stress-induced psychopathology and the need for novel, ...

Antidepressant Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019-2025 - The B Gazette

Antidepressant Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019-2025  The B GazetteAntidepressant Market 2019- Report provides Market analysis with growth opportunities in this market with current and improved data like size, trends, Market ...

FDA approves drug for treating postpartum depression - Roanoke Times

FDA approves drug for treating postpartum depression  Roanoke TimesTRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth.

Depression, Antidepressants, and Atrial Fibrillation: What Do We Know? - The Cardiology Advisor

Depression, Antidepressants, and Atrial Fibrillation: What Do We Know?  The Cardiology AdvisorResearchers found that patients who have atrial fibrillation are more likely to have a history of depression than patients who do not.

Comparing Outcomes of Adjunctive Medications in Patients With Schizophrenia - Psychiatry Advisor

Comparing Outcomes of Adjunctive Medications in Patients With Schizophrenia  Psychiatry AdvisorResearchers found antidepressants to be more effective in reducing hospitalizations for patients with schizophrenia compared with alternative psychotropic ...

Pages